{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-158417","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.198654+00:00","generated_at":"2026-06-01T05:21:23.153542+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Royalty Pharma closes $1.5B senior notes offering across three tranches","bullets":["Issued $500M 5.150% notes due 2029, $500M 5.400% notes due 2034, $500M 5.900% notes due 2054.","Interest payable semiannually on March 2 and September 2, starting March 2025.","Notes are senior unsecured guaranteed by Royalty Pharma Holdings Ltd.","Issuer may redeem notes at specified prices; change-of-control repurchase provisions apply.","Offering closed June 10, 2024; aggregate principal $1.5B."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-158417","json":"https://secwatch.observer/filing/0001193125-24-158417.json","markdown":"https://secwatch.observer/filing/0001193125-24-158417.md","text":"https://secwatch.observer/filing/0001193125-24-158417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312524158417/0001193125-24-158417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312524158417/d851509d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:21:23.153542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}